anumigilimab   Click here for help

GtoPdb Ligand ID: 11761

Synonyms: CSL-324 | CSL324
Compound class: Antibody
Comment: Anumigilimab (CSL-324) is a clinical stage monoclonal antibody that targets colony stimulating factor 3 receptor (CSF3R). It was developed by CSL Behring for potential efficacy in inflammatory/autoimmune diseases. The heavy and light chain peptide sequences for anumigilimab are claimed in patent WO2012171057A1 [1].
Click here for help
Classification Click here for help
Compound class Antibody
International Nonproprietary Names Click here for help
INN number INN
11718 anumigilimab
Synonyms Click here for help
CSL-324 | CSL324
Database Links Click here for help
Specialist databases
IMGT/mAb-DB 1180
Other databases
GtoPdb PubChem SID 458923796
Search PubMed clinical trials anumigilimab
Search PubMed titles anumigilimab
Search PubMed titles/abstracts anumigilimab